Malaria initiative.
Caplan
Arthur
A
D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D037621:Artemisinins / Q000009:adverse effects / Q000627:therapeutic use*; D026688:Bioethical Issues; D006801:Humans; D007391:International Cooperation; D008288:Malaria / Q000517:prevention & control*; D011482:Protective Devices
D000962:Antimalarials; D037621:Artemisinins